Abstract
Restrictive patenting and licensing for cell-free fetal DNA testing has serious consequences for technology advances and benef ts to public health.
Original language | English (US) |
---|---|
Article number | 144fs23 |
Journal | Science translational medicine |
Volume | 4 |
Issue number | 144 |
DOIs | |
State | Published - Jul 25 2012 |
ASJC Scopus subject areas
- General Medicine